Find comprehensive information on Mitral Valve Replacement including clinical documentation requirements, medical coding guidelines, ICD-10 codes for mitral valve disorders, postoperative care, and healthcare resources. Learn about mitral valve stenosis, mitral valve regurgitation, mitral valve prolapse, and the implications for accurate medical coding and billing. Explore resources for healthcare professionals regarding mitral valve repair, replacement procedures, and relevant clinical terminology for optimal documentation and coding accuracy.
Also known as
Replacement of mitral valve
Insertion of mitral valve prosthesis.
Replacement of tricuspid valve
Insertion of tricuspid valve prosthesis.
Replacement of aortic valve
Insertion of aortic valve prosthesis.
Presence of heart valve prosthesis
Indicates a patient has an artificial heart valve.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the mitral valve replacement mechanical?
When to use each related code
| Description |
|---|
| Mitral Valve Replacement |
| Mitral Valve Repair |
| Mitral Valve Stenosis |
Coding lacks detail on the specific type of mitral valve replacement (mechanical, bioprosthetic, etc.), impacting DRG and reimbursement.
Incorrect CPT/ICD-10-PCS codes for the approach (minimally invasive vs. open) can lead to claim denials and compliance issues.
Insufficient documentation of pre-existing conditions impacting MVR complexity may result in undercoding and lost revenue.
Q: What are the most current evidence-based guidelines for patient selection in minimally invasive mitral valve replacement surgery versus conventional open-heart surgery?
A: Minimally invasive mitral valve replacement (MIMVR) offers potential benefits like reduced surgical trauma, shorter hospital stays, and improved cosmetic outcomes compared to conventional open sternotomy. However, patient selection is crucial. The 2020 American Heart Association/American College of Cardiology guidelines emphasize shared decision-making with the patient, considering factors such as anatomical suitability (e.g., mitral valve pathology, left ventricular function, concomitant procedures), patient comorbidities (e.g., porcelain aorta, previous cardiac surgery), and surgeon experience. Consider implementing a heart team approach involving cardiac surgeons, interventional cardiologists, and imaging specialists to determine the optimal surgical approach. Explore how risk stratification tools like the Society of Thoracic Surgeons (STS) risk score can help personalize treatment recommendations. Learn more about emerging techniques in MIMVR, such as robotic-assisted surgery, and their evolving role in patient selection.
Q: How can I effectively differentiate between mitral valve repair and mitral valve replacement options when discussing treatment strategies with patients experiencing severe mitral regurgitation?
A: Differentiating between mitral valve repair and replacement for severe mitral regurgitation requires a nuanced approach. Mitral valve repair, when feasible, is often preferred due to its potential for preserving left ventricular function and lower long-term morbidity. Factors favoring repair include favorable valve anatomy, absence of extensive calcification or leaflet destruction, and surgeon expertise in repair techniques. However, mitral valve replacement becomes necessary when repair is deemed technically challenging or unlikely to achieve durable results. Replacement options include mechanical and bioprosthetic valves, each with its own set of advantages and disadvantages regarding durability, anticoagulation requirements, and potential for reoperation. Consider implementing a patient-centered approach by clearly explaining the risks and benefits of both procedures using shared decision-making tools. Explore the latest clinical trial data comparing long-term outcomes of repair versus replacement in specific patient subgroups.
Patient presents with symptomatic mitral valve disease requiring mitral valve replacement. The patient's primary symptoms include dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, and fatigue, consistent with moderate to severe mitral regurgitation/stenosis. Diagnostic workup including echocardiography, electrocardiogram, and chest x-ray confirmed the diagnosis of severe mitral valve disease, demonstrating [specific echocardiographic findings such as left atrial enlargement, left ventricular hypertrophy, mitral valve leaflet thickening, calcification, restricted motion, or regurgitant jet]. The patient's medical history includes [relevant comorbidities such as hypertension, atrial fibrillation, coronary artery disease, or prior cardiac interventions]. After thorough discussion of risks and benefits, including the option of mitral valve repair versus replacement, the patient elected to proceed with mitral valve replacement. Surgical intervention is indicated to alleviate symptoms, improve cardiac function, and reduce the risk of long-term complications such as heart failure and pulmonary hypertension. The planned procedure is [specify type of replacement: mechanical valve or bioprosthetic valve] mitral valve replacement via sternotomy/minimally invasive approach. Preoperative clearance including laboratory tests, pulmonary function tests, and cardiac catheterization [if indicated] will be completed. Postoperative management will include standard cardiac surgical care, anticoagulation management [if mechanical valve], and cardiac rehabilitation. This intervention is deemed medically necessary. ICD-10 code Z95.1 (presence of cardiac and vascular implants and grafts) and appropriate procedural codes will be applied upon completion of the procedure.